NEW YORK (GenomeWeb) – With $15.6 million in Series A funding, early-stage life sciences company Arbor Biotechnologies came out of stealth mode last week.
CRISPR Startup Arbor Biotechnologies, Salk Institute Concurrently Discover New Cas13d Enzyme
Source: CRISPR Startup Arbor Biotechnologies, Salk Institute Concurrently Discover New Cas13d Enzyme
Get the full story with
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Published at Fri, 23 Mar 2018 14:41:50 +0000
Leave a Reply
You must be logged in to post a comment.